Article Versions Notes

Maeda Y, Teraoka H, Okada A, Yamamoto M, Natsuyama S, Hieda Y, Nagatsuka Y, Sato Y, Goromaru T, Murakami T. Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline. Pharmaceutics. 2023; 15(6):1589. https://doi.org/10.3390/pharmaceutics15061589

Maeda, Yorinobu, Honoka Teraoka, Ami Okada, Mirei Yamamoto, Shintaro Natsuyama, Yuhzo Hieda, Yuka Nagatsuka, Yuhki Sato, Takeshi Goromaru, and Teruo Murakami. 2023. "Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline" Pharmaceutics 15, no. 6: 1589. https://doi.org/10.3390/pharmaceutics15061589

Maeda, Y., Teraoka, H., Okada, A., Yamamoto, M., Natsuyama, S., Hieda, Y., Nagatsuka, Y., Sato, Y., Goromaru, T., & Murakami, T. (2023). Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline. Pharmaceutics, 15(6), 1589. https://doi.org/10.3390/pharmaceutics15061589